Tradestie Institutional Equity Comparison Engine

OVID vs CVM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OVID Overall Edge

OVID Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ovid Therapeutics Inc. Common Stock (OVID) driven by superior Valuation, Momentum & Technical, Options & Structure while CVM counters with relative strength in Growth & Margin. Fundamentally, OVID trades at 1.8x Forward P/E with -4693.7% operating margin (-88.3% YoY revenue) versus CVM at 23.0x Forward P/E and 0.0% operating margin (-62.7% YoY). In options structure, OVID sits in CONSOLIDATION (34th %ile IV; Dealer Gamma Walls on Pro) against CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner OVID
OVID 1.8x vs CVM 23.0x Fwd P/E
Growth & Margin Winner CVM
Op Margin -4693.7% vs 0.0% ยท YoY -88.3% vs -62.7%
Momentum & Technical Winner OVID
1Y +114.6% vs -77.5% ยท 52W Pos 72% vs 10%
Options & Structure Winner OVID
CONSOLIDATION (34th %ile IV) vs BREAKDOWN (N/A IV)
OVID NASDAQ
Ovid Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.58
+1.38% 1D
Market Cap $462.6M
1M Return +19.77%
1Y Return +114.58%
Forward P/E 1.8x
Unified AI Score
44.9 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 67.0 Mom 50.0
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OVID +114.58% CVM -77.48% Spread: +173.3 pp (OVID Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period OVID Revenue CVM Revenue OVID Op. Margin CVM Op. Margin Margin Edge
FY2013 N/A $0M N/A -12450.1% CVM
FY2014 N/A $0M N/A -9721.4% CVM
FY2020 $10M N/A -645.4% N/A OVID
FY2021 $210M N/A 59.6% N/A OVID
FY2022 $0M N/A -3696.4% N/A OVID
FY2023 $0M N/A -15122.7% N/A OVID
FY2024 $0M N/A -10933.7% N/A OVID
FY2025 $10M N/A -585.2% N/A OVID

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OVID (6) vs CVM (3)
Institutional Metric OVID CVM Criterion Row Winner
Market Capitalization Scale $462.6M $20.9M Larger Scale OVID
Trailing P/E Ratio Valuation 1.8x 23.0x Lower Multiple OVID
Forward P/E Ratio Valuation 1.8x 23.0x Lower Multiple OVID
Revenue Growth (YoY) Growth -88.3% -62.7% Higher Growth CVM
Operating Margin (TTM) Profitability -4693.7% 0.0% Higher Margin CVM
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -35.4% -252.5% Higher ROE OVID
52-Week Range Position Momentum 72% ($1โ€“$3) 10% ($1โ€“$8) Stronger Trend OVID
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 97% Vol 0.65ฮฒ ยท 120% Vol Lower Realized Risk OVID
Unified Institutional Score Composite Signal 44.9 / 100 (HOLD) 56.6 / 100 (HOLD) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OVID vs CVM Buy Guide
OVID CONSOLIDATION
150d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OVID Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OVID nor CVM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.